PPTI receives its first contribution for Drug Testing in Rhabdomyosarcoma

We thank our anonymous donor for a kind $500 contribution towards the Pediatric Preclinical Testing Initiative, with the specific goal of advancing new treatments for alveolar rhabdomyosarcoma.

For more information about the Pediatric Preclinical Testing Initiative and our grass-roots effort to advance research in childhood cancers, email Charles at kellerc2@uthscsa.edu .

[right: this graphic design and implemented by Charles Keller and David Rodriguez.]